Cargando…
U.S National Institutes of Health funding towards SARS-CoV-2 prevention and therapeutic scientific efforts: Is it enough?
Autores principales: | Alfaro, Sophie, Sen-Crowe, Brendon, McKenny, Mark, Elkbuli, Adel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492012/ https://www.ncbi.nlm.nih.gov/pubmed/34631045 http://dx.doi.org/10.1016/j.amsu.2021.102780 |
Ejemplares similares
-
A closer look at U.S COVID-19 vaccination rates and the emergence of new SARS-CoV-2 variants: It's never late to do the right thing
por: Alfaro, Sophie, et al.
Publicado: (2021) -
COVID-19 fatalities by zip codes and socioeconomic indicators across various U.S. regions
por: Sen-Crowe, Brendon, et al.
Publicado: (2021) -
Significance and implications of accurate and proper citations in clinical research studies
por: Ngatuvai, Micah, et al.
Publicado: (2021) -
Public health prevention and emergency preparedness funding in the United States: Are we ready for the next pandemic?
por: Sen-Crowe, Brendon, et al.
Publicado: (2020) -
Obesity implications on SARS-CoV-2 infections' prevalence, hospitalizations, critical care needs, fatalities & vaccination rates: A public health crisis
por: Alfaro, Sophie, et al.
Publicado: (2021)